These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28314330)

  • 21. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
    Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
    Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Role of Lung Immune Scores for Prediction of Survival in Limited-stage Small Cell Lung Cancer.
    SchnÖller L; KÄsmann L; Taugner J; Abdo R; Eze C; Manapov F
    In Vivo; 2021; 35(2):929-935. PubMed ID: 33622885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment.
    Manapov F; Klöcking S; Niyazi M; Belka C; Hildebrandt G; Fietkau R; Klautke G
    Strahlenther Onkol; 2012 Jan; 188(1):29-34. PubMed ID: 22189436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of delays in diagnosis and treatment on survival in small cell lung cancer patients.
    Radzikowska E; Roszkowski-Sliz K; Chabowski M; Glaz P
    Adv Exp Med Biol; 2013; 788():355-62. PubMed ID: 23835998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patients.
    Fiegl M; Pircher A; Waldthaler C; Gamerith G; Kocher F; Pall G; Nevinny M; Schmid T; Sterlacci W; Jamnig H; Zangerl G; Zabernigg A; Oberaigner W; Hilbe W
    Lung Cancer; 2014 May; 84(2):168-74. PubMed ID: 24646832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival impact of prophylactic cranial irradiation in small-cell lung cancer in the modern era of magnetic resonance imaging staging.
    Lim YJ; Song C; Kim HJ; ;
    Radiat Oncol; 2022 Feb; 17(1):26. PubMed ID: 35123531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?
    Farooqi AS; Holliday EB; Allen PK; Wei X; Cox JD; Komaki R
    Radiother Oncol; 2017 Feb; 122(2):307-312. PubMed ID: 28073578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
    You B; Tranchand B; Girard P; Falandry C; Ribba B; Chabaud S; Souquet PJ; Court-Fortune I; Trillet-Lenoir V; Fournel C; Tod M; Freyer G
    Lung Cancer; 2008 Nov; 62(2):261-72. PubMed ID: 18442869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancer.
    Liu X; Jiang T; Li W; Li X; Zhao C; Shi J; Zhao S; Jia Y; Qiao M; Zhang L; Luo J; Gao G; Zhou F; Wu F; Chen X; He Y; Ren S; Su C; Zhou C
    Lung Cancer; 2018 Jan; 115():109-115. PubMed ID: 29290250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
    Chu X; Li S; Xia B; Chu L; Yang X; Ni J; Zou L; Li Y; Xie C; Lin J; Zhu Z
    Radiat Oncol; 2019 Sep; 14(1):171. PubMed ID: 31533763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.
    Shaw EG; Su JQ; Eagan RT; Jett JR; Maksymiuk AW; Deigert FA
    J Clin Oncol; 1994 Nov; 12(11):2327-32. PubMed ID: 7964948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of radiation in extensive stage small cell lung cancer: a National Cancer Database registry analysis.
    Sheikh S; Dey A; Datta S; Podder TK; Jindal C; Dowlati A; Efird JT; Machtay M; Biswas T
    Future Oncol; 2021 Jul; 17(21):2713-2724. PubMed ID: 33960209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period.
    Hansen O; Sørensen P; Hansen KH
    Lung Cancer; 2010 Apr; 68(1):111-4. PubMed ID: 19535164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis.
    Rule WG; Foster NR; Meyers JP; Ashman JB; Vora SA; Kozelsky TF; Garces YI; Urbanic JJ; Salama JK; Schild SE
    J Geriatr Oncol; 2015 Mar; 6(2):119-26. PubMed ID: 25482023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
    Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
    BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy in small-cell lung cancer: where should it go?
    Paumier A; Le Péchoux C
    Lung Cancer; 2010 Aug; 69(2):133-40. PubMed ID: 20605651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of PET staging in limited-stage small-cell lung cancer.
    Xanthopoulos EP; Corradetti MN; Mitra N; Fernandes AT; Kim M; Grover S; Christodouleas JP; Evans TL; Stevenson JP; Langer CJ; Lee TT; Pryma DA; Lin LL; Simone CB; Apisarnthanarax S; Rengan R
    J Thorac Oncol; 2013 Jul; 8(7):899-905. PubMed ID: 23608814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival and prognostic factors in limited stage small cell lung cancer: A retrospective study from northeast Turkey.
    Aynaci Ö; Canyilmaz E; Serdar L; Kandaz M; Bahat ZM; Yoney A
    J Cancer Res Ther; 2016; 12(1):238-43. PubMed ID: 27072244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer.
    Ozawa Y; Omae M; Fujii M; Matsui T; Kato M; Sagisaka S; Asada K; Karayama M; Shirai T; Yasuda K; Nakamura Y; Inui N; Yamada K; Yokomura K; Suda T
    BMC Cancer; 2015 Aug; 15():589. PubMed ID: 26275617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens.
    Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.